Rights and permissions
About this article
Cite this article
FDA in favour of labelling change for leukotriene inhibitors. React. Wkly. 1257, 2 (2009). https://doi.org/10.2165/00128415-200912570-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200912570-00002